Grant: Discovery Grants Program - Individual
University of Alberta
$38,000.00
Mechanics of Inhaled Aerosols
EF 2014-15
Résumé
The delivery of medical aerosols into the respiratory tract is an important method of treating respiratory diseases such as asthma, and is under development for many other diseases. However, at present, no method exists that allows inhaled drug to deposit in a specific, targeted region of the lungs, although previous work by us, and others, has demonstrated targeting of magnetic particles. Unfortunately, few drugs are magnetic. Instead, in the present application, we propose to use ultrasound to control the motion of inhaled aerosol particles. If successful, this radical approach would allow noninvasive targeting of nonmagnetic drugs in the lungs, something that has never been achieved previously. In addition, the development of new or improved inhalation aerosol drugs would be greatly aided if the amount of drug delivered past the mouth-throat into the lungs could be easily tested on the laboratory benchtop. While the major worldwide supplier of inhaler testing equipment now sells a device developed by us for this purpose in adults, no such tool has ever been rigorously developed for delivery of aerosol drugs in children or infants. In the present application, we propose to create idealized pediatric replicas of the oral and nasal airways. This will allow the future development and optimization of medical aerosols for use in children. Because respiratory disorders in children are also thought to cause changes in craniofacial structure, we intend to characterize aerosol deposition in replicas of pediatric subjects with craniofacial abnormalities brought on by respiratory disorders in order to determine its effect on drug delivery to the lungs in such patients. This will be important in determining whether different idealized child geometries need to be developed for these patient populations. Finally, mathematical models for use in optimizing inhaled aerosol therapy using alternative gases (helium-oxygen) will also be developed for improving aerosol delivery to patients with severe respiratory distress. The research proposed in the present application addresses groundbreaking aspects in the mechanics of inhalation aerosols and will allow improved future development of therapeutic aerosol drug delivery.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
36359-2012
Name nom
Finlay, Warren
Department département
Mechanical Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2012
Award amount
38000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
3
Nb partie
5
Application title
Mechanics of Inhaled Aerosols
Keyword
NSERC
Application summary
The delivery of medical aerosols into the respiratory tract is an important method of treating respiratory diseases such as asthma, and is under development for many other diseases. However, at present, no method exists that allows inhaled drug to deposit in a specific, targeted region of the lungs, although previous work by us, and others, has demonstrated targeting of magnetic particles. Unfortunately, few drugs are magnetic. Instead, in the present application, we propose to use ultrasound to control the motion of inhaled aerosol particles. If successful, this radical approach would allow noninvasive targeting of nonmagnetic drugs in the lungs, something that has never been achieved previously. In addition, the development of new or improved inhalation aerosol drugs would be greatly aided if the amount of drug delivered past the mouth-throat into the lungs could be easily tested on the laboratory benchtop. While the major worldwide supplier of inhaler testing equipment now sells a device developed by us for this purpose in adults, no such tool has ever been rigorously developed for delivery of aerosol drugs in children or infants. In the present application, we propose to create idealized pediatric replicas of the oral and nasal airways. This will allow the future development and optimization of medical aerosols for use in children. Because respiratory disorders in children are also thought to cause changes in craniofacial structure, we intend to characterize aerosol deposition in replicas of pediatric subjects with craniofacial abnormalities brought on by respiratory disorders in order to determine its effect on drug delivery to the lungs in such patients. This will be important in determining whether different idealized child geometries need to be developed for these patient populations. Finally, mathematical models for use in optimizing inhaled aerosol therapy using alternative gases (helium-oxygen) will also be developed for improving aerosol delivery to patients with severe respiratory distress. The research proposed in the present application addresses groundbreaking aspects in the mechanics of inhalation aerosols and will allow improved future development of therapeutic aerosol drug delivery.